HSBC Holdings’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-88,657
Closed -$13.4M 2806
2022
Q3
$13.4M Sell
88,657
-242
-0.3% -$36.7K 0.02% 627
2022
Q2
$12.9M Buy
88,899
+84,342
+1,851% +$12.3M 0.02% 676
2022
Q1
$545K Sell
4,557
-2,278
-33% -$272K ﹤0.01% 2016
2021
Q4
$953K Buy
6,835
+3,442
+101% +$480K ﹤0.01% 1670
2021
Q3
$456K Sell
3,393
-413
-11% -$55.5K ﹤0.01% 1869
2021
Q2
$369K Buy
+3,806
New +$369K ﹤0.01% 1973